Table 2: Association between current ICS use and COVID-19 Death in ONS - Asthma Population
				Univariable		Age/Sex Adjusted		Age/Sex and Comorbidity Adjusted		
	Events	Person-weeks	Rate per 1,000	HR	95% CI	HR	95% CI	HR	95% CI
SABA only	49	   1021455	0.05	1.00 (ref)		1.00 (ref)		1.00 (ref)
ICS (Low/Medium Dose)	375	   5736155	0.07	1.36	1.01 - 1.84	1.02	0.76 - 1.37	1.14	0.85 - 1.54
ICS (High Dose)	105	    951654	0.11	2.30	1.64 - 3.23	1.61	1.15 - 2.27	1.55	1.10 - 2.18

